Xi Tian, Xiaolin Lu, Hailiang Zhang, Dingwei Ye. "A kidney-sparing approach using disitamab vedotin plus toripalimab for high-risk upper urinary tract urothelial carcinoma in patients with impaired renal function: Preliminary results from a phase II trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16607